Extensively drug-resistant Klebsiella pneumoniae ST307 outbreak, north-eastern Germany, June to October 2019

Sebastian Haller, Rolf Kramer, Karsten Becker, Jürgen A. Bohnert, Tim Eckmanns, Jörg B. Hans, Jane Hecht, Claus-Dieter Heidecke, Nils‐Olaf Hübner, Axel Krämer,

Eurosurveillance · 2019 · 93 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

From June to October 2019, 17 patients (six infected, 11 colonised) with an extensively drug-resistant (XDR) Klebsiella pneumoniae strain were notified from four Western Pomerania medical facilities. The XDR K. pneumoniae produced carbapenemases NDM-1 and OXA-48, and was only susceptible to chloramphenicol, tigecycline and cefiderocol. Synergistic activity was observed for the combination of aztreonam plus ceftazidime-avibactam. Genomic analyses showed all isolates belonged to K. pneumoniae sequence type 307. Control measures and further investigations are ongoing.

References

14